{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:08:55Z","timestamp":1787990935082,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      ) remains a major cause of community acquired pneumonia (CAP), particularly among older adults. In China, pneumococcal infections pose a substantial disease burden, with rising antibiotic resistance. Although vaccines have effectively reduced disease worldwide, data on adult serotype distribution and resistance in China are scarce. This study investigates serotype patterns and antimicrobial susceptibility of\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      among Chinese adults.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We collected a total of 474\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      isolates from adult patients diagnosed with pneumococcal infections in 14 cities across five geographic regions of China between 2018 and 2019. Clinical specimens included sputum, blood, bronchoalveolar lavage fluid (BALF), cerebrospinal fluid (CSF), pharyngeal and nasal swabs, and middle ear fluid. Minimum inhibitory concentrations (MICs) of antimicrobial agents were determined using the agar dilution method. Pneumococcal serotyping was performed using the Pneumotest-Latex kit and type-specific antisera.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serotype 19F was the most prevalent across all age groups, specimen types, and regions. 20-valent pneumococcal conjugate vaccine (PCV20) is expected to provide the highest serotype coverage (69.4%) among all vaccines evaluated. Multidrug resistance was detected in over 94% of isolates, with high resistance to macrolides, tetracycline, and clindamycin. \u03b2-lactam resistance varied by syndrome and region. Non-invasive isolates showed slightly higher resistance than invasive ones. Serotypes covered by higher-valency vaccines were more likely to be antibiotic-resistant, although fluoroquinolone and vancomycin resistance remained low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings highlight a high burden of antimicrobial resistance and predominance of specific serotypes, particularly 19F, among adult\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      isolates in China. The broad serotype coverage of PCV20 suggests its potential advantage in future adult immunization strategies. Continued surveillance of serotype distribution and resistance patterns is essential to inform vaccine policy and guide effective antibiotic use.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11377-5","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:21:25Z","timestamp":1754389285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Distribution of serotypes and antibiotic resistance profiles of Streptococcus pneumoniae in hospitalized adult patients: aretrospective multicenter surveillance in China (2018\u20132019)"],"prefix":"10.1186","volume":"25","author":[{"given":"Chunjiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"6","key":"11377_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","volume":"16","author":"JN Weiser","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355\u201367.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"11377_CR2","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","volume":"6","author":"B Wahl","year":"2018","unstructured":"Wahl B, O\u2019Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315. Lancet Glob Health. 2018;6(7):e744\u201357.","journal-title":"Lancet Glob Health"},{"key":"11377_CR3","doi-asserted-by":"publisher","first-page":"107268","DOI":"10.1016\/j.ijid.2024.107268","volume":"149","author":"X Yu","year":"2024","unstructured":"Yu X, Wang H, Ma S, Chen W, Sun L, Zou Z. Estimating the global and regional burden of lower respiratory infections attributable to leading pathogens and the protective effectiveness of immunization programs. Int J Infect Dis. 2024;149:107268.","journal-title":"Int J Infect Dis"},{"key":"11377_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1472-6963-14-56","volume":"14","author":"D Che","year":"2014","unstructured":"Che D, Zhou H, He J, Wu B. Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination. BMC Health Serv Res. 2014;14:56.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"11377_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jiph.2022.06.016","volume":"15","author":"L Kang","year":"2022","unstructured":"Kang L, Jing W, Liu Q, Liu J, Liu M. The trends of mortality, aetiologies and risk factors of lower respiratory infections in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. J Infect Public Health. 2022;15(8):870\u20136.","journal-title":"J Infect Public Health"},{"issue":"38","key":"11377_CR6","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1016\/j.vaccine.2019.09.065","volume":"38","author":"SH Kim","year":"2020","unstructured":"Kim SH, Chung DR, Song J-H, Baek JY, Thamlikitkul V, Wang H, et al. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: emergence of drug-resistant non-vaccine serotypes. Vaccine. 2020;38(38):6065\u201373.","journal-title":"Vaccine"},{"issue":"6","key":"11377_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/infdis\/149.6.861","volume":"149","author":"RM Douglas","year":"1984","unstructured":"Douglas RM, Miles HB. Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis. 1984;149(6):861\u20139.","journal-title":"J Infect Dis"},{"key":"11377_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12889-016-2785-7","volume":"16","author":"ML Boulton","year":"2015","unstructured":"Boulton ML, Ravi NS, Sun X, Huang Z, Wagner AL. Trends in childhood pneumococcal vaccine coverage in Shanghai, China, 2005\u20132011: a retrospective cohort study. BMC Public Health. 2015;16:109.","journal-title":"BMC Public Health"},{"issue":"12","key":"11377_CR9","doi-asserted-by":"publisher","first-page":"e82361","DOI":"10.1371\/journal.pone.0082361","volume":"8","author":"C Zhao","year":"2013","unstructured":"Zhao C, Zhang F, Chu Y, Liu Y, Cao B, Chen M, et al. Phenotypic and genotypic characteristic of invasive pneumococcal isolates from both children and adult patients from a multicenter surveillance in China 2005\u20132011. PLoS ONE. 2013;8(12):e82361.","journal-title":"PLoS ONE"},{"issue":"3","key":"11377_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00937-20","volume":"11","author":"F Ganaie","year":"2020","unstructured":"Ganaie F, Saad JS, McGee L, van Tonder AJ, Bentley SD, Lo SW, et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus. MBio. 2020;11(3):10.","journal-title":"MBio"},{"issue":"1","key":"11377_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32\u201341.","journal-title":"J Infect Dis"},{"issue":"6","key":"11377_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3201\/eid2706.204238","volume":"27","author":"M Wasserman","year":"2021","unstructured":"Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, et al. Twenty-year public health impact of 7- and 13-valent pneumococcal conjugate vaccines in US children. Emerg Infect Dis. 2021;27(6):1627\u201336.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"11377_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1586\/erv.09.78","volume":"8","author":"M Rose","year":"2009","unstructured":"Rose M, Zielen S. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe. Expert Rev Vaccines. 2009;8(10):1351\u201364.","journal-title":"Expert Rev Vaccines"},{"key":"11377_CR14","unstructured":"Kim YA-O, LaFon DA-O, Nahm MH. Indirect effects of pneumococcal conjugate vaccines in national immunization programs for children on adult pneumococcal disease. (2093\u20132340 (Print))."},{"key":"11377_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","volume":"71","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the advisory committee on immunization practices\u2014United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:109\u201317.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11377_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","volume":"6","author":"A Djennad","year":"2018","unstructured":"Djennad A, Ramsay ME, Pebody R, Fry NK, Sheppard C, Ladhani SN, et al. Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales. EClinicalMedicine. 2018;6:42\u201350.","journal-title":"EClinicalMedicine"},{"key":"11377_CR17","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.lanepe.2021.100126","volume":"7","author":"S Perniciaro","year":"2021","unstructured":"Perniciaro S, van der Linden M. Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: a retrospective cohort study. Lancet Reg Health Eur. 2021;7:100126.","journal-title":"Lancet Reg Health Eur"},{"key":"11377_CR18","unstructured":"(CLSI) CaLSI. Performance standards for antimicrobial susceptibility testing; thirty-third informational supplement. Wayne: CLSI; 2023. Report No.: M100-Ed33"},{"issue":"1","key":"11377_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s12879-017-2880-0","volume":"17","author":"C Zhao","year":"2017","unstructured":"Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. 2017;17(1):804.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11377_CR20","first-page":"838","volume":"79","author":"WH Self","year":"2024","unstructured":"Self WH, Johnson KD, Resser JJ, Whitney CG, Baughman A, Kio M, et al. Prevalence, clinical severity, and serotype distribution of pneumococcal pneumonia among adults hospitalized with community-acquired pneumonia in Tennessee and Georgia, 2018\u20132022. Clin Infect Dis. 2024;79(4):838\u201347.","journal-title":"Clin Infect Dis"},{"key":"11377_CR21","doi-asserted-by":"publisher","first-page":"1458307","DOI":"10.3389\/fmicb.2024.1458307","volume":"15","author":"T Miyazaki","year":"2024","unstructured":"Miyazaki T, van der Linden M, Hirano K, Maeda T, Kohno S, Gonzalez EN, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates cultured from Japanese adult patients with community-acquired pneumonia in Goto City. Jpn Front Microbiol. 2024;15:1458307.","journal-title":"Jpn Front Microbiol"},{"issue":"1","key":"11377_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3343\/alm.2023.43.1.45","volume":"43","author":"GR Kim","year":"2023","unstructured":"Kim GR, Kim EY, Kim SH, Lee HK, Lee J, Shin JH, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive pneumococcal disease in Korea between 2017 and 2019 after introduction of the 13-valent pneumococcal conjugate vaccine. Ann Lab Med. 2023;43(1):45\u201354.","journal-title":"Ann Lab Med"},{"issue":"1","key":"11377_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/07853890.2022.2160877","volume":"55","author":"G Hascelik","year":"2023","unstructured":"Hascelik G, Soyletir G, Gulay Z, Sancak B, Yaman A, Gurler N, et al. Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018. Ann Med. 2023;55(1):266\u201375.","journal-title":"Ann Med"},{"issue":"1","key":"11377_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/21645515.2020.1757996","volume":"17","author":"MC Li","year":"2021","unstructured":"Li MC, Wang Y, Zhang H, Liu Y, Chen XJ, et al. Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Hum Vaccin Immunother. 2021;17(1):146\u201356. https:\/\/doi.org\/10.1080\/21645515.2020.1757996.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"11377_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1128\/CMR.00058-15","volume":"29","author":"L Kim","year":"2016","unstructured":"Kim L, McGee L, Tomczyk S, Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective. Clin Microbiol Rev. 2016;29(3):525\u201352.","journal-title":"Clin Microbiol Rev"},{"key":"11377_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","volume":"6","author":"MR Schroeder","year":"2016","unstructured":"Schroeder MR, Stephens DS. Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"11377_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3201\/eid1106.050198","volume":"11","author":"G Barkai","year":"2005","unstructured":"Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis. 2005;11(6):829\u201337.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"11377_CR28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/424467","volume":"190","author":"CA Rodriguez","year":"2004","unstructured":"Rodriguez CA, Atkinson R, Bitar W, Whitney CG, Edwards KM, Mitchell L, et al. Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis. 2004;190(8):1481\u20137.","journal-title":"J Infect Dis"},{"issue":"11","key":"11377_CR29","doi-asserted-by":"publisher","first-page":"e0078523","DOI":"10.1128\/aac.00785-23","volume":"67","author":"C Higgs","year":"2023","unstructured":"Higgs C, Kumar LS, Stevens K, Strachan J, Korman T, Horan K, et al. Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants. Antimicrob Agents Chemother. 2023;67(11):e0078523.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"11377_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/00365541003754451","volume":"42","author":"KL Nielsen","year":"2010","unstructured":"Nielsen KL, Hammerum AM, Lambertsen LM, Lester CH, Arpi M, Knudsen JD, et al. Characterization and transfer studies of macrolide resistance genes in Streptococcus pneumoniae from Denmark. Scand J Infect Dis. 2010;42(8):586\u201393.","journal-title":"Scand J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11377-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:35:00Z","timestamp":1757356500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11377-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11377"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11377-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6513636\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Peking University People\u2019s Hospital (approval No. 2018PHB129) and conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was waived due to the retrospective nature of the study and the use of anonymized data, as approved by the Institutional Review Board of Ethics Committee of Peking University People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"980"}}